Changes in SARS-CoV-2 Antibody Titers from Three to Nine Months after Administration of the BNT162b2 mRNA Vaccine among Healthcare Workers in Japan: A Prospective Study.

Mochizuki, Takeshi; Hori, Takaki; Yano, Koichiro; Ikari, Katsunori; Okazaki, Ken

Mochizuki, Takeshi; Hori, Takaki; Yano, Koichiro; Ikari, Katsunori; Okazaki, Ken.

Mochizuki T; Department of Rheumatology and Orthopedic Surgery, Kamagaya General Hospital, Japan.
Hori T; Department of Cardiovascular Surgery, Kamagaya General Hospital, Japan.
Yano K; Department of Orthopedic Surgery, Tokyo Women's Medical University, Japan.
Ikari K; Department of Orthopedic Surgery, Tokyo Women's Medical University, Japan.
Okazaki K; Department of Orthopedic Surgery, Tokyo Women's Medical University, Japan.

Intern Med ; 61(13): 2095, 2022 07 01.

Article in English | MEDLINE | ID: covidwho-1993653

Subject(s)

BNT162 Vaccine; COVID-19; Antibodies, Viral; COVID-19/prevention & control; Health Personnel; Humans; Japan; Prospective Studies; SARS-CoV-2; Vaccines, Synthetic; mRNA Vaccines

Keywords

Japan; SARS-CoV-2 antibody titer; healthcare workers; vaccine

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / BNT162 Vaccine Type of study: Cohort study / Observational study / Prognostic study Topics: Vaccines Limits: Humans Country/Region as subject: Asia Language: English Journal: Intern Med Journal subject: Internal Medicine Year: 2022 Document Type: Article Affiliation country: Internalmedicine.9695-22

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google